Senate health chair faults abortion drug firms over online sales oversight

Sen. Bill Cassidy, chair of the Senate Health, Education, Labor and Pensions Committee, released a report accusing three mifepristone manufacturers of failing to ensure compliance with FDA safety rules, particularly for pills sold online through third-party vendors. The report calls on the Justice Department and FDA to act, including reinstating an in-person dispensing requirement for the drug. Cassidy cited concerns about unverified prescribers and sales beyond the FDA-approved gestational limit, though he has not announced specific legislative next steps.

EXPANDED:

The committee's investigation spanned months and examined how the three manufacturers oversee distribution through third-party online vendors. Cassidy's report specifically highlights Aid Access